Skip to main content
AMGN
NASDAQ Life Sciences

Amgen Q2 Beat, Raised Guidance, and FDA Talks on TAVNEOS Drive Optimism

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$410.82
Mkt Cap
$222.17B
52W Low
$269.77
52W High
$418.4
52W Position info
52% above low
Off High info
1.8% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

AMGN sits 52% above its 52-week low of $269.77.

Summary

Amgen's Q2 revenue hit $10.1B, beating estimates, and full-year sales guidance was raised to $38.2–39.4B. Oncology sales surged 18% to ~$2B, with Imdelltra contributing $288M and showing a survival benefit. The company is actively engaging with the FDA on TAVNEOS, having submitted a hearing request and supporting materials. TD Cowen raised its price target to $452, reflecting confidence. A new licensing deal for Kaléo's auto-injector tech broadens Amgen's device portfolio. This follows the Q2 beat reported on August 4 and adds fresh details on pipeline progress and analyst sentiment.

At the time of this announcement, AMGN was trading at $410.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $222.2B. The 52-week trading range was $269.77 to $418.40. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AMGN - Latest Insights

AMGN
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $477.40
Real-time Price: $447.59 info
Change: -$29.81 (-6%) info
Market Cap: $242.469B info
AMGN
Nov 03, 2026, 6:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $464.92
Real-time Price: $447.59 info
Change: -$17.33 (-4%) info
Market Cap: $242.469B info
AMGN
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $463.00
Real-time Price: $447.59 info
Change: -$15.41 (-3%) info
Market Cap: $242.469B info
AMGN
Nov 03, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.57
Real-time Price: $447.59 info
Change: -$12.98 (-3%) info
Market Cap: $242.469B info
AMGN
Oct 26, 2026, 9:23 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $448.79
Real-time Price: $447.59 info
Change: -$1.20 (-0.27%) info
Market Cap: $242.469B info